The following excerpt is from the company's SEC filing.
– Shire plc (LSE: SHP, NASDAQ: SHPG), will announce first quarter 2016 earnings on Friday April 29, 2016.
Results press release will be issued at:
12:00 BST / 07:00 EDT
Investor conference call time:
14:00 BST / 09:00 EDT
Live conference call for investors:
Flemming Ornskov, Chief Executive Officer and Jeff Poulton, Chief Financial Officer will host the investor and analyst conference call at 9:00 EDT / 14:00 BST.
The details of the conference call are as follows:
UK dial in:
0808 237 0030 or 020 3139 4830
US dial in:
1 866 928 7517 or 1 718 873 9077
International Access Numbers:
A replay of the presentation will be available for two weeks by phone and by webcast for three months. Replay information can be found on the Investor Relations section of Shire’s website at
For further information please contact:
+44 1256 894157
+1 781 482 9018
+44 1256 894874
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Shire plc makes a similar move, sign up!
Other recent filings from the company include the following:
Departure of Directors or Principal - Dec. 8, 2017
Shire Appoints Andreas Busch, Ph D As Head Of Research And Development And Chief Scientific Officer - Dec. 1, 2017
Shire To Appoint Thomas Dittrich As Chief Financial Officer And Member Of The Board Of Directors - Nov. 24, 2017